Influence of environmental deterioration on renal health: a narrative review
Abstract
Anthropogenic activities have contributed to the rapid degradation of the environment, which carries a significant risk to the health of people on a global scale. The kidneys are highly sensitive to the characteristics of people's environment, so aspects such as pollution, water scarcity or global warming are ways through which environmental deterioration can have an impact on kidney health. Because kidney disease usually develops gradually without presenting clinical manifestations in the early stages, it is important to know the potential factors associated with its appearance with the intention of being able to undertake preventive measures, especially in populations with a higher risk of exposure to these factors. For this reason, this manuscript presents a narrative review about the possible causes of kidney disease derived from the deterioration of the environment.
Downloads
References
Gordon Ada. 2005. Overview of vaccines and vaccination. Mol Biotechnol 29, 3 (March 2005), 255–272. DOI:https://doi.org/10.1385/MB:29:3:255
Adeel Afzal. 2020. Molecular diagnostic technologies for COVID-19: Limitations and challenges. J Adv Res 26, (August 2020), 149–159. DOI:https://doi.org/10.1016/j.jare.2020.08.002
S. Akash, Baskaran Sivaprakash, Natarajan Rajamohan, C. Muruga Pandiyan, and Dai-Viet N. Vo. 2022. Pesticide pollutants in the environment – A critical review on remediation techniques, mechanism and toxicological impact. Chemosphere 301, (August 2022), 134754. DOI:https://doi.org/10.1016/j.chemosphere.2022.134754
Sohail Akhtar, Jamal Abdul Nasir, and Andrew Hinde. 2020. The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis. BMC Public Health 20, 1 (April 2020), 587. DOI:https://doi.org/10.1186/s12889-020-8414-5
Brook K. Baker. 2016. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere. PLOS Medicine 13, 3 (March 2016), e1001970. DOI:https://doi.org/10.1371/journal.pmed.1001970
Patricia Botella-Pavía and Manuel Rodríguez-Concepción. 2006. Carotenoid biotechnology in plants for nutritionally improved foods. Physiologia Plantarum 126, 3 (2006), 369–381. DOI:https://doi.org/10.1111/j.1399-3054.2006.00632.x
Ereck Chakauya, Katy M. Coxon, Heather M. Whitney, Jennifer L. Ashurst, Chris Abell, and Alison G. Smith. 2006. Pantothenate biosynthesis in higher plants: advances and challenges. Physiologia Plantarum 126, 3 (2006), 319–329. DOI:https://doi.org/10.1111/j.1399-3054.2006.00683.x
Abdallah S. Daar, Halla Thorsteinsdóttir, Douglas K. Martin, Alyna C. Smith, Shauna Nast, and Peter A. Singer. 2002. Top ten biotechnologies for improving health in developing countries. Nat Genet 32, 2 (October 2002), 229–232. DOI:https://doi.org/10.1038/ng1002-229
Shakeela Daud, Saqib Shahzad, Muhammad Shafique, Munir Ahmad Bhinder, Muhammad Niaz, Asif Naeem, Zia ur Rehman, and Tayyab Husnain. 2014. Optimization and Validation of PCR protocol for three Hypervariable Regions (HVI, HVII and HVIII) in Human Mitochondrial DNA. Advancements in Life Sciences 1, 3 (May 2014), 165–170.
Theo Dingermann. 2008. Recombinant therapeutic proteins: production platforms and challenges. Biotechnol J 3, 1 (January 2008), 90–97. DOI:https://doi.org/10.1002/biot.200700214
M. Dua, A. Singh, N. Sethunathan, and A. K. Johri. 2002. Biotechnology and bioremediation: successes and limitations. Appl Microbiol Biotechnol 59, 2–3 (July 2002), 143–152. DOI:https://doi.org/10.1007/s00253-002-1024-6
Bradford D. Gessner, David Kaslow, Jacques Louis, Kathleen Neuzil, Katherine L. O’Brien, Valentina Picot, Tikki Pang, Umesh D. Parashar, Mitra Saadatian-Elahi, and Christopher B. Nelson. 2017. Estimating the full public health value of vaccination. Vaccine 35, 46 (November 2017), 6255–6263. DOI:https://doi.org/10.1016/j.vaccine.2017.09.048
Subhrajyoti Ghosh, Karabi Datta, and Swapan K. Datta. 2019. 7 - Rice vitamins. In Rice (Fourth Edition), Jinsong Bao (ed.). AACC International Press, 195–220. DOI:https://doi.org/10.1016/B978-0-12-811508-4.00007-1
Klaus Graumann and Andreas Premstaller. 2006. Manufacturing of recombinant therapeutic proteins in microbial systems. Biotechnol J 1, 2 (February 2006), 164–186. DOI:https://doi.org/10.1002/biot.200500051
Varsha Gupta, Manjistha Sengupta, Jaya Prakash, and Baishnab Charan Tripathy. 2016. An Introduction to Biotechnology. Basic and Applied Aspects of Biotechnology (October 2016), 1–21. DOI:https://doi.org/10.1007/978-981-10-0875-7_1
Mohamed F. Hamoda. 2006. Air pollutants emissions from waste treatment and disposal facilities. J Environ Sci Health A Tox Hazard Subst Environ Eng 41, 1 (2006), 77–85. DOI:https://doi.org/10.1080/10934520500298895
Ian M Head and Richard PJ Swannell. 1999. Bioremediation of petroleum hydrocarbon contaminants in marine habitats. Current Opinion in Biotechnology 10, 3 (June 1999), 234–239. DOI:https://doi.org/10.1016/S0958-1669(99)80041-X
Takahiro Ishikawa, John Dowdle, and Nicholas Smirnoff. 2006. Progress in manipulating ascorbic acid biosynthesis and accumulation in plants. Physiologia Plantarum 126, 3 (2006), 343–355. DOI:https://doi.org/10.1111/j.1399-3054.2006.00640.x
A. Ito, T. Takachi, J. Aizawa, and T. Umita. 2001. Chemical and biological removal of arsenic from sewage sludge. Water Science and Technology 44, 10 (November 2001), 59–64. DOI:https://doi.org/10.2166/wst.2001.0581
Meena Kapahi and Sarita Sachdeva. 2019. Bioremediation Options for Heavy Metal Pollution. J Health Pollut 9, 24 (December 2019), 191203. DOI:https://doi.org/10.5696/2156-9614-9.24.191203
Divjot Kour, Tanvir Kaur, Rubee Devi, Ashok Yadav, Manali Singh, Divya Joshi, Jyoti Singh, Deep Chandra Suyal, Ajay Kumar, Vishnu D. Rajput, Ajar Nath Yadav, Karan Singh, Joginder Singh, Riyaz Z. Sayyed, Naveen Kumar Arora, and Anil Kumar Saxena. 2021. Beneficial microbiomes for bioremediation of diverse contaminated environments for environmental sustainability: present status and future challenges. Environ Sci Pollut Res Int 28, 20 (May 2021), 24917–24939. DOI:https://doi.org/10.1007/s11356-021-13252-7
Zhenhua Li, Pengzhi Dong, Meijing Ren, Yawen Song, Xiaolong Qian, Yiling Yang, Shuai Li, Xinmin Zhang, and Fangfang Liu. 2016. PD-L1 Expression Is Associated with Tumor FOXP3+ Regulatory T-Cell Infiltration of Breast Cancer and Poor Prognosis of Patient. J Cancer 7, 7 (April 2016), 784–793. DOI:https://doi.org/10.7150/jca.14549
Angelique Y. Louie, Martina M. Hüber, Eric T. Ahrens, Ute Rothbächer, Rex Moats, Russell E. Jacobs, Scott E. Fraser, and Thomas J. Meade. 2000. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18, 3 (March 2000), 321–325. DOI:https://doi.org/10.1038/73780
Paola Lucca, Richard Hurrell, and Ingo Potrykus. 2002. Fighting Iron Deficiency Anemia with Iron-Rich Rice. Journal of the American College of Nutrition 21, sup3 (June 2002), 184S-190S. DOI:https://doi.org/10.1080/07315724.2002.10719264
I. P. Nascimento and L. C. C. Leite. 2012. Recombinant vaccines and the development of new vaccine strategies. Braz J Med Biol Res 45, 12 (December 2012), 1102–1111. DOI:https://doi.org/10.1590/s0100-879x2012007500142
Organización Mundial de la Salud. 2020. Las 10 principales causas de muerte. Retrieved March 31, 2021 from https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
C. J. Palmer, J. F. Lindo, W. I. Klaskala, J. A. Quesada, R. Kaminsky, M. K. Baum, and A. L. Ager. 1998. Evaluation of the OptiMAL test for rapid diagnosis of Plasmodium vivax and Plasmodium falciparum malaria. J Clin Microbiol 36, 1 (January 1998), 203–206. DOI:https://doi.org/10.1128/JCM.36.1.203-206.1998
Jeroen Pollet, Wen-Hsiang Chen, and Ulrich Strych. 2021. Recombinant protein vaccines, a proven approach against coronavirus pandemics. Adv Drug Deliv Rev 170, (March 2021), 71–82. DOI:https://doi.org/10.1016/j.addr.2021.01.001
Marcus Shaker, Elizabeth Phillips, Kimberly G. Blumenthal, Elissa M. Abrams, Aleena Banerji, John Oppenheimer, Timothy K. Vander Leek, Douglas P. Mack, Paige G. Wickner, Alexander G. Singer, David A. Khan, and Matthew Greenhawt. 2021. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract 9, 7 (July 2021), 2556–2561. DOI:https://doi.org/10.1016/j.jaip.2021.04.015
Gary Walsh. 2003. Pharmaceutical biotechnology products approved within the European Union. European Journal of Pharmaceutics and Biopharmaceutics 55, 1 (January 2003), 3–10. DOI:https://doi.org/10.1016/S0939-6411(02)00165-0
Kazuya Watanabe. 2001. Microorganisms relevant to bioremediation. Current Opinion in Biotechnology 12, 3 (June 2001), 237–241. DOI:https://doi.org/10.1016/S0958-1669(00)00205-6
Rebecca E. Watson, Catherine F. Jacobson, Amy Lavin Williams, W. Brian Howard, and John M. DeSesso. 2006. Trichloroethylene-contaminated drinking water and congenital heart defects: A critical analysis of the literature. Reproductive Toxicology 21, 2 (February 2006), 117–147. DOI:https://doi.org/10.1016/j.reprotox.2005.07.013
World Health Organization. 2021. Malnutrition. Retrieved September 5, 2022 from https://www.who.int/news-room/fact-sheets/detail/malnutrition
World Health Organization. Enfermedades Transmisibles - OPS/OMS | Organización Panamericana de la Salud. Retrieved September 5, 2022 from https://www.paho.org/es/temas/enfermedades-transmisibles
Lu Zhang, Wei Wang, and Shixia Wang. 2015. Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines 14, 11 (2015), 1509–1523. DOI:https://doi.org/10.1586/14760584.2015.1081067
Michael B. Zimmermann and Kristien Boelaert. 2015. Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol 3, 4 (April 2015), 286–295. DOI:https://doi.org/10.1016/S2213-8587(14)70225-6
Copyright (c) 2023 Yaneth Citlalli Orbe Orihuela, Carlos Eduardo Bautista-Bautista , José Roberto Campos-Flores , José Ángel Hernández-Mariano
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
